arrow
E

Emmanouil G. Sifakis

Department of Oncology-Pathology
H指数:12
被引数:859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glucocorticoid prophylaxis influences the systemic immune macroenvironment in patients with early stage, treatment naïve, HER2+ breast cancer

糖皮质激素预防对早期、治疗初治、HER2阳性乳腺癌患者的全身免疫宏观环境的影响

2026-08-250
OA
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助palbociclib联合内分泌治疗与化疗在ER+/HER2-乳腺癌中的比较:一项随机II期试验

2026-04-080
OAAI
Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data

计算病理学注释增强了乳腺癌空间转录组学数据的分辨率和解释。

2025-09-090
OAAI
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer
2024-12-270
PRE
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images

揭示模型不可知的多尺度分析的力量,以增强乳腺癌组织病理学图像中的人工智能模型

2024-09-010
OA
Correlative and longitudinal transcriptomic profiling predicts patient outcomes and the efficacy of neoadjuvant HER2-targeted treatments in the randomized PREDIX HER2 trial
2023-03-010
PRE
Longitudinal tumor-immune microenvironment changes in patients with clinical luminal A early breast cancer treated with neoadjuvant palbociclib and endocrine therapy: results from the Swedish randomized PREDIX Luminal A trial
2023-03-010
PRE
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction

用于有效药物分析和治疗反应预测的乳腺癌患者来源的全肿瘤细胞培养模型

2022-12-275
OAAI